Tenders/ACQUISITION OF MEDICINE OUTSIDE THE PHARMACOLOGICAL LIST EMICIZUMAB 60 MG-AM AND EMICIZUMAB 105 MG /0.7ML-AM FOR PATIENTS OF THE HEMATOLOGICAL CLINICAL SERVICE OF HNGAI - ESSALUD
Awarded🇵🇪PeruSupplies

ACQUISITION OF MEDICINE OUTSIDE THE PHARMACOLOGICAL LIST EMICIZUMAB 60 MG-AM AND EMICIZUMAB 105 MG /0.7ML-AM FOR PATIENTS OF THE HEMATOLOGICAL CLINICAL SERVICE OF HNGAI - ESSALUD

Auto-translated from Spanish
Original title: Adquisicion de medicamento fuera de petitorio farmacologico emicizumab 60 mg-am y emicizumab 105 mg /0.7ml-am pa pacientes del servicio de hematologica clinica del hngai - essalud
SEGURO SOCIAL DE SALUD
Published: Dec 29, 2023
Updated: Jun 18, 2026
Source: peru_seace

About This Opportunity

Translated

This tender concerns the acquisition of specific medications, Emicizumab 60 mg-AM and Emicizumab 105 mg/0.7ml-AM, which are outside the established pharmacological list. These drugs are intended for patients receiving treatment within the Hematological Clinical Service of the Hospital Nacional Guillermo Almenara Irigoyen (HNGAI), operated by ESSALUD (Peruvian Social Health Insurance). The contracting entity is the Seguro Social de Salud (ESSALUD), and the procurement process is taking place in the Lima department. This is a Direct Procurement process, identified by the reference number DIRECTA-PROC-42-2023-ESSALUD-RPA-1. The method of contracting is Direct Contracting, indicating a specific circumstance that allows for bypassing the standard competitive bidding process. The tender focuses on ensuring the availability of critical treatments for patients with hematological conditions who require Emicizumab, a medication used to prevent or treat bleeding episodes in individuals with hemophilia A. The procurement aims to address an urgent need or a situation where standard procurement channels are not suitable for obtaining these specialized pharmaceuticals. The successful bidder will be responsible for supplying these medications to the HNGAI, ensuring continuity of care for the affected patient population. This procurement highlights ESSALUD's commitment to providing advanced medical treatments, even when they fall outside the routine formulary, to meet the specific and critical needs of its beneficiaries.

This is a supplies contract in the health and medical services and finance and banking sectors, with a focus on Pharmaceuticals and Insurance. Located in Peru, Latin America, this opportunity is open to firms and consortiums, with an estimated budget of PEN 72,896.

Published through Peru SEACE, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.

Description

Original language: Spanish

ADQUISICION DE MEDICAMENTO FUERA DE PETITORIO FARMACOLOGICO EMICIZUMAB 60 MG-AM Y EMICIZUMAB 105 MG /0.7ML-AM PA PACIENTES DEL SERVICIO DE HEMATOLOGICA CLINICA DEL HNGAI - ESSALUD

Entidad contratante: SEGURO SOCIAL DE SALUD

Departamento: LIMA

Proceso: DIRECTA-PROC-42-2023-ESSALUD-RPA-1

Metodo de contratacion: Contratación Directa

Data provenance

This notice is sourced from Peru SEACE and was originally published on December 29, 2023. Last refreshed 7 days ago. Reference: 983810. Original language: Spanish. BidsFactory mirrors official procurement notices and links back to the source for full legal text.

About SEGURO SOCIAL DE SALUD

SEGURO SOCIAL DE SALUD has issued 1,358 procurement notices on BidsFactory, including 16 currently open and 996 awarded contracts. Activity concentrates in Health & Medical, Governance & Public Administration, and Information & Communication Technology. All notices are published for Peru. Notices are distributed via Peru SEACE. Most recent publication: June 3, 2026.

Frequently asked questions about this tender

How much was the contract awarded for?

CONSORCIO QUIMICA SUIZA S.A.C. - ROCHE FARMA (PERU) S.A. was awarded the contract for PEN 72,896. The figure reflects the value disclosed by the contracting authority in the award notice.

Where will the contract be performed?

The contract is for delivery in Peru. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.

How can I submit a bid?

Visit Peru SEACE to access the full notice, required documents, and submission instructions. Quote reference 983810 when communicating with the contracting authority.

Is this tender still open?

No — the contract has already been awarded to CONSORCIO QUIMICA SUIZA S.A.C. - ROCHE FARMA (PERU) S.A.. The award notice is archived on BidsFactory for transparency and market intelligence.

Who is the contracting authority?

This notice was issued by SEGURO SOCIAL DE SALUD in Peru. The authority is responsible for evaluating bids, awarding the contract, and managing performance.

What type of contract is this?

This is a Supplies contract in the Health & Medical sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.

Find tenders like this automatically

Set up alerts and filters that match your business — never miss a relevant opportunity again.

See plans

Key Details

Estimated Budget
PEN 72,896 - PEN 72,896
Contract Type
Supplies
Eligibility
Firms / Consortiums
Language
Spanish
Reference
983810

Source

peru_seace
peru_seace
Official Source

Contracting Authority

SEGURO SOCIAL DE SALUD
🇵🇪Peru

Matching Experts

Are you a consultant?

Join our Expert Network and get matched with relevant tenders.